Weis Center for Research, Geisinger Clinic, Danville, Pennsylvania, USA.
PLoS One. 2009 Oct 28;4(10):e7472. doi: 10.1371/journal.pone.0007472.
Heme (Fe2+ protoporphyrin IX) is an essential molecule that has been implicated the potent antimalarial action of artemisinin and its derivatives, although the source and nature of the heme remain controversial. Artemisinins also exhibit selective cytotoxicity against cancer cells in vitro and in vivo. We demonstrate that intracellular heme is the physiologically relevant mediator of the cytotoxic effects of artemisinins. Increasing intracellular heme synthesis through the addition of aminolevulinic acid, protoporphyrin IX, or transferrin-bound iron increased the cytotoxicity of dihydroartemisinin, while decreasing heme synthesis through the addition of succinyl acetone decreased its cytotoxic activity. A simple and robust high throughput assay was developed to screen chemical compounds that were capable of interacting with heme. A natural products library was screened which identified the compound coralyne, in addition to artemisinin, as a heme interacting compound with heme synthesis dependent cytotoxic activity. These results indicate that cellular heme may serve a general target for the development of both anti-parasitic and anti-cancer therapeutics.
血红素(Fe2+原卟啉 IX)是一种重要的分子,它被认为是青蒿素及其衍生物具有强大抗疟作用的原因,尽管血红素的来源和性质仍存在争议。青蒿素类药物在体外和体内也表现出对癌细胞的选择性细胞毒性。我们证明细胞内血红素是青蒿素类药物细胞毒性作用的生理相关介质。通过添加氨基乙酰丙酸、原卟啉 IX 或转铁蛋白结合铁增加细胞内血红素合成,可提高二氢青蒿素的细胞毒性,而通过添加丁二酮肟降低血红素合成则降低其细胞毒性活性。开发了一种简单而强大的高通量测定法,用于筛选能够与血红素相互作用的化合物。筛选天然产物文库,除了青蒿素之外,还确定了化合物考来啉是一种与血红素合成相关的化合物,具有血红素依赖的细胞毒性活性。这些结果表明,细胞内血红素可能成为开发抗寄生虫和抗癌治疗药物的通用靶点。